Is early treatment of anaemia with epoetin- beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial | Zendy

Iain C. Macdougall | Zendy; R. M. Temple | Zendy; J.T.C. Kwan | Zendy

Open Access

Is early treatment of anaemia with epoetin- beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial

Author(s) -

Iain C. Macdougall,

R. M. Temple,

J.T.C. Kwan

Publication year - 2006

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl483

Subject(s) - medicine , kidney disease , dialysis , randomized controlled trial , contraindication , group b , hemodialysis , gastroenterology , erythropoietin , prospective cohort study , surgery , anemia , pathology , alternative medicine

This multicentre, open-label prospective, randomized, comparative-group study evaluated the effects of maintaining haemoglobin (Hb) in pre-dialysis chronic kidney disease (CKD) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research